Equities

Tekla Healthcare Opportunities Fund

THQ:NYQ

Tekla Healthcare Opportunities Fund

Actions
FinancialsClosed End Investments
  • Price (USD)20.36
  • Today's Change-0.11 / -0.54%
  • Shares traded51.49k
  • 1 Year change-13.58%
  • Beta0.8982
Data delayed at least 15 minutes, as of Dec 09 2022 19:52 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Tekla Healthcare Opportunities Fund (the Fund) is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation through investments in United States and non-United States companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. The Fund invests primarily in securities of public and private companies. The Fund invests up to 20 % of managed assets, measured at the time of investment, in the debt of healthcare companies. The Fund also invests in private companies and other restricted securities, including private investments in public equity and venture capital investments. It invests in health care providers and services, pharmaceuticals, health care equipment and supplies, life sciences tools and services, biotechnology, and medical devices and diagnostics. The Fund's investment adviser is Tekla Capital Management LLC.

  • Revenue in USD (TTM)19.91m
  • Net income in USD111.97m
  • Incorporated2014
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SLR Investment Corp159.09m5.46m811.73m0.00105.320.8067--5.100.14070.14073.2818.370.0698--8.57--0.23982.970.29313.6550.1553.423.4337.65--1.090.533127.1714.46-1.70285.52-11.02--0.4951
Digital World Acquisition Corp0.00-11.25m812.77m----2.97-----0.3022-0.30220.007.340.00-------3.79---3.89--------------0.0125--------------
John Hancock Tax-Advantage Dvd Incom Fd.-100.00bn-100.00bn821.70m0.00------------------------------------------------------------
Winmark Corporation80.66m40.84m825.07m85.0021.42--19.9510.2311.2011.2022.14-17.571.826.8953.27948,934.1092.0868.50123.2489.9095.5396.4750.6343.101.7720.805.3535.3218.403.2933.8512.50-59.5934.02
BlackRock Resources&Commdts Strtgy Trst181.80m48.80m846.07m--17.340.963--4.650.55250.55252.069.950.2052--68.53--5.516.225.546.2494.7579.2326.84126.45--1.400.008597.06400.65--1,834.20-0.931---2.15
Tekla Healthcare Opportunities Fund19.91m111.97m846.56m--7.560.8578--42.522.712.710.481523.860.0168--4.82--9.428.469.448.6020.2026.50562.37406.84----0.185761.000.6156-0.85566.8817.05---3.93
Abrdn Total Dynamic Dividend Fund-100.00bn-100.00bn860.32m--------------------------------------------------------------
AllianceBernstein Global Hgh Incm Fd Inc-100.00bn-100.00bn860.57m0.00------------------------------------------------------------
Blackrock Muniyield Quality Fund Inc.-100.00bn-100.00bn863.31m----0.8487----------20.04----------------------------0.1255--------------
Apollo Strategic Growth Capital II0.0019.44m864.23m--47.111.31135.31--0.21270.21270.007.630.00------2.80--2.84--------------0.0075------606,982.70------
Longview Acquisition Corp II0.0025.25m865.95m--34.561.31----0.29050.29050.007.650.00------3.65--3.67--------------0.005------487,040.80------
Pontem Corp0.0024.15m867.68m--35.931.31----0.28000.28000.007.690.00------3.49--3.49--------------0.0009------17,134.60------
Eaton Vance Enhanced Equity Incme Fnd II9.02m-262.74m870.94m0.00--1.02--96.51-5.13-5.130.174116.550.0088--32.46---25.6817.92-26.1218.08-26.29-23.68-2,911.312,137.70---0.0110.0029.3624.93-0.4187-17.7468.09--4.99
Redwood Trust Inc696.72m-80.52m871.66m298.00--0.7551--1.25-0.6978-0.69785.5810.180.0532--6.432,337,990.00-0.57530.2768-0.68410.329325.6028.94-10.826.63--0.53150.9108365.430.526318.47152.9219.36---6.98
Eaton Vanc Tax-Mngd Glbl Buy-Writ Opp Fd-100.00bn-100.00bn877.87m--------------------------------------------------------------
Brightspire Capital Inc428.98m122.59m884.70m55.007.250.63115.572.060.94630.94633.3310.870.0762--8.777,799,564.002.27-3.562.39-3.7593.1274.4129.80-53.27--1.910.7481--18.0220.6271.40------
Data as of Dec 09 2022. Currency figures normalised to Tekla Healthcare Opportunities Fund's reporting currency: US Dollar USD

Institutional shareholders

14.42%Per cent of shares held by top holders
HolderShares% Held
Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 20221.59m3.86%
Raymond James Financial Services Advisors, Inc.as of 30 Sep 20221.01m2.44%
Raymond James & Associates, Inc. (Invt Mgmt)as of 30 Sep 2022898.42k2.17%
RBC Capital Markets LLC (Investment Management)as of 30 Sep 2022773.71k1.87%
Wells Fargo Clearing Services LLCas of 30 Sep 2022497.70k1.20%
UBS Financial Services, Inc.as of 30 Sep 2022396.28k0.96%
Columbia Management Investment Advisers LLCas of 30 Sep 2022265.80k0.64%
Steward Partners Investment Advisory LLCas of 30 Sep 2022182.59k0.44%
Wolverine Asset Management LLCas of 30 Sep 2022179.96k0.44%
First Trust Advisors LPas of 30 Sep 2022160.96k0.39%
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.